The business case for cell and gene therapies

被引：0

|

作者：

Mohamed Abou-El-Enein

Gerhard Bauer

Petra Reinke

机构：

[1] Berlin-Brandenburg Center for Regenerative Therapies,Department of Nephrology and Internal Intensive Care

[2] Charité University Medicine,undefined

[3] Charité University Medicine,undefined

[4] University of California,undefined

[5] Davis,undefined

[6] Institute For Regenerative Cures,undefined

来源：

Nature Biotechnology | 2014年 / 32卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：1192 / 1193

页数：1

相关论文

共 50 条

[1] The business case for cell and gene therapies
Abou-El-Enein, Mohamed
Bauer, Gerhard
Reinke, Petra
NATURE BIOTECHNOLOGY, 2014, 32 (12) : 1192 - 1193
[2] Industrializing cell and gene therapies
Shanley, Agnes
Pharmaceutical Technology, 2019, 2019 (04)
[3] TRANSLATION OF CELL AND GENE THERAPIES
Narayanan, G.
CYTOTHERAPY, 2016, 18 (06) : S23 - S23
[4] The Rise of Cell and Gene Therapies
Hilas, Olga
US PHARMACIST, 2024, 49 (10)
[5] Industrializing Cell and Gene Therapies
Shanley, Agnes
BIOPHARM INTERNATIONAL, 2019, 32 (08) : 10 - +
[6] Gene and cell therapies in demand
King, Anthony
CHEMISTRY & INDUSTRY, 2019, 83 (05) : 8 - 8
[7] Gene and stem cell therapies
Kaji, EH
Leiden, JM
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05): : 545 - 550
[8] Gene and Cell Based Therapies
Barker, R.
MOVEMENT DISORDERS, 2010, 25 : S598 - S599
[9] Contributions of Gene Marking to Cell and Gene Therapies
Barese, Cecilia N.
Dunbar, Cynthia E.
HUMAN GENE THERAPY, 2011, 22 (06) : 659 - 668
[10] Schwann cell gene therapies in sight
Stephan Züchner
Gene Therapy, 2021, 28 : 618 - 619

← 1 2 3 4 5 →